This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stanford, CA (US) (2015)
- Menlo Park, CA (US) (2013 - 2023)
Company Filing History:
Years Active: 2013-2023
Title: Innovations in Cancer Therapy by Alexander Filatenkov
Introduction
Alexander Filatenkov is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of cancer therapy, holding a total of 8 patents. His work focuses on innovative methods for treating cancer, particularly through vaccination and cell transplantation techniques.
Latest Patents
Among his latest patents is a method for treating cancer that combines tumor cell vaccination with hematopoietic and immune cell transplantation. This invention outlines a process that may involve autologous tumor cell vaccination prior to the transplantation of hematopoietic and immune cells. Another notable patent addresses anti-tumor T cell immunity induced by high-dose radiation. This method involves irradiating an individual at a primary tumor site, collecting T cells after sufficient activation of an anti-tumor response, administering chemotherapy, and reintroducing the T cell population back to the individual.
Career Highlights
Alexander Filatenkov is affiliated with Leland Stanford Junior University, where he continues to advance research in cancer treatment. His innovative approaches have the potential to significantly improve patient outcomes in oncology.
Collaborations
He collaborates with notable professionals in the field, including Samuel Strober, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Alexander Filatenkov's contributions to cancer therapy through his patents and research at Leland Stanford Junior University highlight his commitment to advancing medical science. His innovative methods may pave the way for more effective cancer treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
